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a b s t r a c t
Astaxanthin is a red-colored carotenoid, used as food and feed additive. Astaxanthin is mainly produced
by chemical synthesis, however, the process is expensive and synthetic astaxanthin is not approved for
human consumption. In this study, we engineered the oleaginous yeast Yarrowia lipolytica for de novo
production of astaxanthin by fermentation.
First, we screened 12 different Y. lipolytica isolates for b-carotene production by introducing two genes
for b-carotene biosynthesis: bi-functional phytoene synthase/lycopene cyclase (crtYB) and phytoene
desaturase (crtI) from the red yeast Xanthophyllomyces dendrorhous. The best strain produced
31.1 ± 0.5 mg/L b-carotene. Next, we optimized the activities of 3-hydroxy-3-methylglutaryl-coenzyme A
reductase (HMG1) and geranylgeranyl diphosphate synthase (GGS1/crtE) in the best producing strain and
obtained 453.9 ± 20.2 mg/L b-carotene. Additional downregulation of the competing squalene synthase
SQS1 increased the b-carotene titer to 797.1 ± 57.2 mg/L. Then we introduced b-carotene ketolase (crtW)
from Paracoccus sp. N81106 and hydroxylase (crtZ) from Pantoea ananatis to convert b-carotene into
astaxanthin. The constructed strain accumulated 10.4 ± 0.5 mg/L of astaxanthin but also accumulated
astaxanthin biosynthesis intermediates, 5.7 ± 0.5 mg/L canthaxanthin, and 35.3 ± 1.8 mg/L echinenone.
Finally, we optimized the copy numbers of crtZ and crtW to obtain 3.5 mg/g DCW (54.6 mg/L) of
astaxanthin in a microtiter plate cultivation.
Our study for the ﬁrst time reports engineering of Y. lipolytica for the production of astaxanthin. The
high astaxanthin content and titer obtained even in a small-scale cultivation demonstrates a strong
potential for Y. lipolytica-based fermentation process for astaxanthin production.
© 2017 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
1. Introduction
Astaxanthin is a red-colored carotenoid with a global annual
market of 250 tonnes worth $447million [1]. Astaxanthin is used to
improve the color of farmed ﬁsh, to increase the pigmentation of
egg yolks, and for other feed applications. There is also a growing
interest in using astaxanthin in food and cosmetics due to its
powerful antioxidant activity [2]. The main source of astaxanthin is
currently the chemical synthesis from petrochemical sources. The
disadvantages of the chemical process are the high cost of the
precursors, side reactions, and the fact that chemical astaxanthin is
not approved for human consumption due to the presence of by-
products. Several biotechnological processes have been devel-
oped, but remain too expensive to compete with chemical syn-
thesis. A biological process based on the microalgae Haematococcus
pluvialis is challenged with low cell densities, even though
H. pluvialis produces the highest level of astaxanthin (1.5e3.0% dry
weight) compared to other astaxanthin producers [1]. Another
process, employing the native red yeast Xanthophyllomyces den-
drorhous [3,4], suffers from the low cellular content of astaxanthin.
Multiple studies on the engineering of the red yeast in order to
improve astaxanthin accumulation have been published.
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Breitenbach et al. overexpressed geranylgeranyl pyrophosphate
(GGPP) synthase, resulting in an 8-fold increase of astaxanthin
content and reaching 0.45 mg/g dry cell weight (DCW) [5]. In more
recent studies, a combination of mutagenesis and metabolic
pathway engineering resulted in X. dendrorhous astaxanthin con-
tent of up to 9e9.7 mg/g DCW [6,7]. Saccharomyces cerevisiae has
also been engineered for astaxanthin production by expression of
genes encoding astaxanthin synthase (crtS) and cytochrome P450
reductase (crtR) from X. dendrorhous or by expression of b-carotene
ketolase (crtW) from bacteria Paracoccus sp. and b-carotene hy-
drolase (crtZ) from Pantoea ananatis [8]. The transformants that co-
expressed crtW and crtZ accumulated more astaxanthin (0.03 mg/g
DCW) than the strain co-expressing crtS and crtR.
In this study, we aimed to engineer oleaginous yeast Y. lipolytica
for high-level production of astaxanthin. This yeast species is an
attractive host for the production of carotenoids because of its
naturally high supply of carotenoids precursor, cytosolic acetyl-
CoA, and redox co-factor NADPH [9e12]. Y. lipolytica has a GRAS
status and is genetically more accessible than X. dendrorhous [13].
2. Materials and methods
2.1. Strains, culture conditions and chemicals
Escherichia coli DH5a was used for DNA manipulation in this
study. E. coliwas grown at 37 C and 300 rpm in Lysogeny Broth (LB)
liquid medium and at 37 C on LB solid medium plates supple-
mented with 20 g/L agar. Ampicillin was supplemented when
required at a concentration of 100 mg/L.
Y. lipolytica strain GB20 (mus51D, nugm-Htg2, ndh2i, lys11,
leu2, ura3, MatB) was obtained from Volker Zickermann (Goethe
University Medical School, Institute of Biochemistry II, Germany).
Other strains were obtained from ARS Culture Collection (NRRL)
collection. All strains used in this study are listed in Supplementary
Tables 1 and 2. Y. lipolytica was grown at 30 C on yeast extract
peptone dextrose (YPD) or synthetic complete (SC) media supple-
mented with 20 g/L agar for preparation of solid media. Synthetic
drop out media was used for selection of strains expressing auxo-
trophic markers. Supplementation of antibiotics was done when
necessary at the following concentrations: hygromycin B at 50mg/L
and nourseothricin at 250 mg/L. Cultivation of recombinant strains
for carotenoids production was performed in yeast extract peptone
medium containing 80 g/L glucose instead of 20 g/L glucose (YPþ8%
glucose). The chemicals were obtained, if not indicated otherwise,
from Sigma-Aldrich. Nourseothricin was purchased from Jena
Bioscience GmbH (Germany).
2.2. Plasmid construction
The genes encoding phytoene synthase/lycopene cyclase
(crtYB), phytoene desaturase (crtI) and geranylgeranyl diphosphate
synthase (crtE) from X. dendrorhous were obtained from Addgene
[14]. Genes encoding X. dendrorhous astaxanthin synthase crtS
(GenBank accession number AX034665) and cytochrome P450
reductase crtR (GeneBank accession number EU884134), Paracoccus
sp. N81106 b-carotene ketolase crtW (GenBank accession number
AB206672) and P. ananatis b-carotene hydrolase crtZ (GenBank
accession number D90087) were codon-optimized for Y. lipolytica
and synthesized as GeneArt String DNA fragments by Thermo
Fisher Scientiﬁc.
The plasmids, BioBricks, and primers used in this study are listed
in Supplementary Table 3, 4, and 5, respectively. BioBricks were
ampliﬁed by PCR using Phusion U polymerase (Thermo Fisher
Scientiﬁc) under the following conditions: 98 C for 30 s; 6 cycles of
98 C for 10 s, 51 C for 20 s and 72 C for 30 s/kb; 26 cycles of 98 C
for 10 s, 58 C for 20 s and 72 C for 30 s/kb, and 72 C for 5 min.
BioBricks were puriﬁed from agarose gels using the NucleoSpin®
Gel and PCR Clean-up kit (Macherey-Nagel). BioBricks were
assembled by into EasyCloneYALI vectors using USER cloning [15].
BioBricks were incubated in CutSmart® buffer (New England
Biolabs) with USER enzyme and the parental vector for 25 min at
37 C, followed by 10 min at 25 C, 10 min at 20 C and 10 min at
15 C. Prior to the USER reaction, the parental vectors were digested
with FastDigest AsiSI (Thermo Fisher Scientiﬁc) and nicked with Nb.
BsmI (New England Biolabs). The USER reactions were transformed
into chemically competent E. coli DH5a. Correct assembly was
veriﬁed by sequencing.
2.3. Construction of Y. lipolytica strains
The yeast vectors were integrated into different previously
characterized intergenic loci in Y. lipolytica genome as described in
Holkenbrink et al. [15]. Prior to the transformation, the integrative
vectors were linearized with FastDigest NotI (Thermo Fisher Sci-
entiﬁc). The digestion reaction was transformed into Y. lipolytica
using a lithium-acetate protocol [16]. Transformants were selected
on YPD þ Hygromycin/Nourseothricin or SC (-ura) plates. Trans-
formants carrying the correct integration of the DNA construct into
the Y. lipolytica genome were veriﬁed by colony PCR. Marker loop-
out was performed by transformation of the strains with a Cre-
recombinase episomal vector pCfB4158. Obtained colonies were
cultivated in liquid SC (-leu) medium for 24 h for induction of the
Cre recombinase and plated on SC (-leu) plates to obtain single
colonies.
The strains with downregulated squalene synthase were con-
structed by transformation of b-carotene producing strains with
BioBricks as detailed in Supplementary Table 4. Obtained colonies
were selected on SC (-ura) plates and the correct transformants
were conﬁrmed by colony PCR using primers listed in
Supplementary Table 5.
2.4. Cultivation of Y. lipolytica
For pre-culture preparation, single colonies were inoculated
from fresh plates in 3 mL YPD in 24-well plates with air-penetrable
lid (EnzyScreen, NL) and grown for 18 h at 30 C and 300 rpm
agitation at 5 cm orbit cast.
The required volume of the inoculum was transferred to
3 mLYPþ8% glucose for an initial optical density at 600 nm (OD600)
of 0.1 into new 24-well plates. The plates were incubated for 72 h at
30 C with 300 rpm agitation.
To screen the astaxanthin producing strains, generated by
integration of astaxanthin genes into rDNA loci, we picked 10
clones for each transformation and streaked them on SC (-ura)
plates. The resulting single colonies were inoculated into 500 mL of
YPD in 96 deep-well plates with air-penetrable lid (EnzyScreen,
NL). The plates were incubated for 18 h at 30 C with 300 rpm
agitation. 30 mL of this culture were used to inoculate three wells
with 500 mL YPþ8% glucose in a new 96 deep-well plate. The plates
were incubated at 30 C and 300 rpm for 72 h. After cultivation,
400 mL of the cultivation volume was transferred into a 2 mL
microtube (Sarstedt) for carotenoids extraction and quantiﬁcation
as described further.
2.5. Isoprenoid extraction and sample preparation
After cultivation, OD600 was measured using either a Synergy™
MxMonochromator-Based Multi-Mode Microplate Reader (BioTek)
or NanoPhotometer (Implen GmbH, Germany). The dry-weight of a
sample was measured by taking 1 or 2 mL of fermentation broth
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and ﬁltering through pre-weighted cellulose nitrate membranes
(0.45 mm pore size, 47 mm circle) using a ﬁltration unit with a
vacuum pump. Filters were dried at 60 C for 96 h and weighed on
an analytical balance. The conversion of OD600 values into dry cell
weight was done using the following empirical correlation:
DCW (g/L) ¼ (OD600  0.026)/6.781
2.5.1. Carotenoids extraction
At the end of cultivation, 1 mL of the cultivation broth was
transferred into a 2 mL microtube (Sarstedt) for carotenoids
extraction. Each sample was centrifuged at 10,000  g for 5 min
and the supernatant removed. To each tube, 500 mL of
0.5e0.75 mm glass beads were added. 1 mL of ethyl acetate sup-
plemented with 0.01% 3,5-di-tert-4-butylhydroxy toluene (BHT)
was also added to each tube. BHT was supplemented to prevent
carotenoid oxidation.
Cells were disrupted using a Precellys®24 homogenizer (Bertin
Corp.) in four cycles of 5500 rpm for 20 s. After disruption, the cells
were centrifuged for 5 min at 10,000  g. For total carotenoid
measurement, the solvent fraction was moved to a 96-well plate
and read in BioTek Synergy™ Mx microplate reader with full
spectrum scan (230 nme700 nm) with 5 nm interval. Absorbance
value at 450 nm was used to quantify total carotenoids. For the
measurements of individual carotenoids, the samples were further
processed before HPLC analysis as below.
2.5.2. Carotenoids quantiﬁcation by HPLC
For HPLC measurements, 50e200 mL of ethyl acetate extract
was evaporated in a rotatory evaporator and dry extracts were re-
dissolved in 1 mL 99% ethanol þ0.01% BHT. Extracts were then
analyzed by HPLC (Thermo Fisher Scientiﬁc, Waltham, USA)
equipped with a Discovery HS F5 150 mm  2.1 mm column
(particle size 3 mm). The column oven temperature was set at
30 C. All organic solvents were HPLC grade (Sigma Aldrich). The
ﬂow rate was set at 0.7 mL/min with an initial solvent composi-
tion of 10 mM ammonium formate (pH ¼ 3, adjusted with formic
acid) (solvent A) and acetonitrile (solvent B) (3:1) until min 2.0.
Solvent composition was then changed following a linear gradient
until % A ¼ 10.0 and % B ¼ 90.0 at 4.0 min. This solvent compo-
sition was kept until 10.5 min when the solvent was returned to
initial conditions and the column was re-equilibrated until
13.5 min. The injection volume was 10 mL. Peaks were identiﬁed
by comparison to the prepared standards and integration of the
peak areas was used to quantify carotenoids from obtained
standard curves. b-carotene and echinenone were detected at
retention times 7.6 min and 6.9 min, respectively, by measuring
absorbance at 450 nm. Astaxanthin and canthaxanthin were
detected by absorbance at 475 nm and retention times of 5.9 min
and, 6.4 min respectively.
2.5.3. Squalene extraction and quantiﬁcation
After cultivation, 1 mL of the cultivation was transferred into a
2 mL microtube. Tubes were centrifuged at 10,000  g for 5 min.
The cell pellet was resuspended in 1 mL 99% ethanol supplemented
with 0.01% BHT. 500 mL of 0.5e0.75 mm glass beads were added to
each of the tubes and tubes were incubated at 95 C and 650 rpm
for 60 min. After incubation, cells were disrupted using a Pre-
cellys®24 homogenizer in four cycles of 5500 rpm for 20 s. After
disruption, the cells were centrifuged for 5 min at 10,000  g and
the supernatant was collected for future analysis.
The extracts were analyzed by HPLC. HPLC column, conditions,
and solvents were as described in b-carotene quantiﬁcation.
Squalene was detected by absorbance at 210 nm with a retention
time of 6.9 min. Peaks were identiﬁed by comparison to the pre-
pared standards and the quantiﬁcation was performed using
squalene standard curve generated in the same HPLC run.
3. Results
3.1. Exploring the diversity of Y. lipolytica strains for the production
of carotenoids
Fourteen different Y. lipolytica strains isolated from different
sources were selected as potential hosts for production of b-caro-
tene. We successfully integrated the b-carotene biosynthesis genes
into 12 of the 14 strains. The total carotenoids were extracted from
these strains and quantiﬁed by spectrophotometry. The carotenoid
titer varied from 5.7 to 31 mg/L total carotenoids with the highest
production in the strain ST5204 derived from GB20
(Supplementary Fig. 1). This strain was chosen for further
engineering.
3.2. Optimization of mevalonate pathway
High-level production of isoprenoids in S. cerevisiae required
extensive engineering of the mevalonate pathway [17]. Two steps
that exert high ﬂux control in the mevalonate pathway are 3-
hydroxy-3-methyl-glutarylecoenzyme A reductase (encoded by
HMG1) and geranylgeranyl diphosphate synthase (encoded by crtE
or GGS1 depending on the organism) (Fig.1). Both crtE heterologous
expression and GGS1 overexpression have been shown as effective
strategies to enhance b-carotene production in different organisms
[11,14]. HMG-CoA reductase is a rate-limiting step in the mevalo-
nate pathway and subjected to a strong regulation. Truncation of
the N-terminal region, which contains the membrane-spanning
domain (i.e. amino acid 1-552), and leaving only the catalytic
domain resulted in deregulation of HMG-CoA reductase activity in
S. cerevisiae [18]. In S. cerevisiae, overexpression of the truncated
gene variant (tHMG1) gave a signiﬁcant improvement in sterol and
isoprenoids production [14,17,18]. For example, Verwaal et al. re-
ported 7-fold increase in total carotenoids level producing cells
[14]. The beneﬁcial effect of HMG1 overexpression on the produc-
tion of lycopene and other isoprenoids in Y. lipolytica has also been
reported [11,19]. The performance of the truncated variant Hmg1p
has not previously been compared to the performance of the full-
length Hmg1p in Y. lipolytica. To implement this engineering
strategy in Y. lipolytica, we performed multiple alignment between
Hmg1p from Y. lipolytica (YALI0E04807), S. cerevisiae (YML075C)
and Candida utilis (GeneBank accession number BAA31937.1). The
protein structure of Hmg1p is highly conserved among eukaryotes,
of which the ﬁrst 500 amino acids harbor a membrane associated
N-terminal domain. Thus, we generated a truncated Hmg1p by
deleting the ﬁrst 500 amino acids.
We chose to test the effect of overexpressing a complete or
truncated HMG1 variant together with the expression of GGS1 or
crtE from X. dendrorhous separately and in combinations. The basic
b-carotene producing strain (ST5204) was used in all cases as a
parental strain. All the gene expression cassettes were stably in-
tegrated into the Y. lipolytica genome and the b-carotene concen-
trations were measured by HPLC (Fig. 2A). Among the strains
overexpressing one of the above-mentioned genes, the largest ef-
fect was obtained for GGS1 overexpression (4-fold increase in b-
carotene titer). The overexpression of gene combinations resulted
in further improvement, overexpression of HMG1 together with
either crtE or GGS1 produced 438.4 ± 29.5 or 453.9 ± 20.2 mg/L b-
carotene, respectively (10e10.3-fold increase) [though these com-
binations are not signiﬁcantly different from each other, Student's
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t-test p ¼ 0.5].
3.3. Downregulation of the native squalene synthase increases b-
carotene production
FPP is a common precursor in the mevalonate pathway
including squalene, ubiquinones, ergosterol, other essential sterols,
and GGPP, a substrate for b-carotene. In order to increase the
availability of FPP for carotenoid biosynthesis, we downregulated
the ﬂux towards squalene in one of the b-carotene overproducing
strains (ST5404). We either truncated the native promoter of the
squalene synthase (SQS1) to 500, 100 or 50 base pairs or replaced it
with two alternative Y. lipolytica promoters, PERG1 or PERG11. PERG1 or
PERG11 promoters were chosen based on Yuan et al. (2015) study in
S. cerevisiae, where they found that a number of the genes from
ergosterol biosynthesis pathway were repressed by ergosterol [20].
In our study, the resulting strains gave a 2e2.5 fold increase in b-
carotene titer compared to the reference strainwith the native SQS1
promoter (Fig. 2B). The shortening of the promoter to 50 bp
resulted in the highest b-carotene titer of 797.1 ± 57.2 mg/L.
Squalene accumulation in the engineered strains was surprisingly
higher than in the parental strain, with the exception of the strain
with promoter truncation to 50 bp (Supplementary Fig. 2).
3.4. Establishing the astaxanthin biosynthetic pathway in
Y. lipolytica
After optimizing b-carotene production in Y. lipolytica, we
evaluated two different biosynthetic pathways for production of
astaxanthin. The conversion of b-carotene into astaxanthin requires
two oxidation steps, which can be catalyzed by different enzymes
(Fig. 3A). Here, we tested the astaxanthin biosynthetic pathway
from the red yeast X. dendrorhous (encoded by crtS and crtR), and a
pathway composed of two bacterial genes (encoded by crtW and
crtZ).
In X. dendrorhous, the astaxanthin synthase crtS is responsible
for the conversion of b-carotene into astaxanthin while crtR en-
codes a cytochrome P450 reductase providing electrons to crtS [21].
We introduced a crtS and crtR expression cassette into two different
b-carotene platform strains, a non-optimized (ST5204) and
precursor-optimized strain (ST6899). No signiﬁcant change in col-
ony color was observed in the either of the two resulting strains
(Fig. 3B). HPLC analysis detected small amounts of echinenone, an
astaxanthin intermediate, in the precursor-optimized strain. This
strain also produced a similar b-carotene titer relative to the
parental strain, but no astaxanthin could be detected (Fig. 3C).
The designed bacterial astaxanthin biosynthesis pathway was
composed of a b-carotene ketolase from the marine bacterium
Paracoccus sp. N81106 (crtW) and a b-carotene hydroxylase from
enterobacteriaceae P. ananatis (crtZ). We again expressed both
genes in a non-optimized and in precursor-optimized strains,
leading to strains ST6075 and ST7023, respectively. In this case,
both enzymes are directly catalyzing the oxidation reaction of b-
carotene to astaxanthin. HPLC analysis detected approximately
1.4 ± 0.2 mg/L and 10.4 ± 0.5 mg/L astaxanthin in the engineered
strains without and with precursor optimization, respectively
(Fig. 3B). Furthermore, accumulations of approximately
3.3 ± 0.1 mg/L and 35.3 ± 1.8 mg/L echinenone were observed in
ST6075 and ST7023, respectively. Canthaxanthin could also be
detected, though in lower amounts, ~0.2 ± 0.01 mg/L and
5.7 ± 0.5 mg/L in ST6075 and ST7023, respectively. The colonies of
strain ST7023 had a district red color (Fig. 3B).
3.5. Optimization of astaxanthin production
Accumulation of astaxanthin intermediates indicated that the
ﬂux through the astaxanthin biosynthetic pathway was not efﬁ-
cient. The high concentration of echinenone suggests that expres-
sion of crtZ might be the rate-limiting step in astaxanthin
production in Y. lipolytica. To balance the ratio of crtW and crtZ and
redirect the ﬂux towards astaxanthin production, we constructed
three different vectors expressing either crtW, crtZ or both genes
simultaneously under the control of the strong PTEFintron promoter
[9]. The expression vectors also carried two homologous regions to
target the ribosomal DNA (rDNA) elements in Y. lipolytica and a
URA3 gene (ura3d1 allele) under the regulation of a truncated 43 bp
promoter (Fig. 4A) to promote multiple integration events into the
rDNA loci [22]. As expected, increasing the copy number of crtW
gene had no inﬂuence on astaxanthin production and affected only
slightly the accumulation of echinenone and canthaxanthin (Fig. 4B
and C). On the contrary, increasing the gene copy number of either
crtZ alone or both genes simultaneously led to a signiﬁcant increase
in astaxanthin production up to 6-fold. Integrating crtW and crtZ on
the same plasmid was more effective than integrating the same
genes on separate plasmids, possibly due to the higher overall
number of integrations or better pathway balancing. Overall, any of
the combinations, which should result in a higher molar ratio of
crtZ resulted in improvement of astaxanthin production. These
results conﬁrmed that crtZ is the rate-limiting step in the astax-
anthin biosynthesis pathway. Our best strain ST7403, with multiple
integrations of crtZ and crtW-crtZ, produced 54.6 mg/L astaxanthin
(3.5 mg/g DCW).
4. Discussion
Production of high-value carotenoids via biotechnology is an
attractive alternative to extraction from plant materials and to
Fig. 1. Strategies for optimization of b-carotene production in Y. lipolytica. The
engineered steps are highlighted. Abbreviations: DMAPP, dimethylallyl pyrophos-
phate; IPP, isopenthenyl pyrophosphate; GPP, geranyl pyrophosphate, FPP, farnesyl
pyrophosphate, GGPP, geranylgeranyl pyrophosphate; HMG1 and tHMG1, full-length
and truncated alleles of 3-hydroxy-3-methylglutaryl-coenzyme A reductase from
Y. lipolytica, respectively; crtE and GGS1, GGPP synthase-encoding genes from
X. dendrorhous and Y. lipolytica, respectively; crtYB, phytoene synthase and lycopene
cyclase genes from X. dendrorhous; crtI, phytoene desaturase-encoding gene from
X. dendrorhous; SQS1, squalene synthase gene from Y. lipolytica; PERG1, squalene epox-
idase promoter; PERG11, Lanosterol 14-alpha demethylase promoter; PSQS1, squalene
synthase promoter.
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chemical synthesis. However, the strains need to be improved
before the fermentation processes can become price competitive.
In this study, we engineered Y. lipolytica for the production of a
very high-value carotenoid - astaxanthin. As the ﬁrst step, we
screened 14 different Y. lipolytica strains to identify a strainwith the
best natural potential. The strains varied signiﬁcantly both in the
titer of b-carotene and in genetic amenability. This type of
screening can be recommended, particularly in the beginning of a
strain development program, as also shown by Friedlander et al. for
lipid production [23].
As the next step, we evaluated the effect of modulating the
expression of HMG1 and crtE/GGS1 in the mevalonate pathway on
b-carotene production. Interestingly, our optimal combinations
were different fromwhat was reported for other yeasts. In Candida
utilis, the expression of the truncated HMG1 was more effective
than the expression of the full-length HMG1, leading to 2-fold in-
crease in lycopene production [24]. In S. cerevisiae, most of the
earlier reports expressed truncated HMG1 to enhance isoprenoids
production [8,14]. In Y. lipolytica, full-length HMG1 was overex-
pressed to enhance lycopene and limonene production [11,19].
During the preparation of thismanuscript, a report by Gao et al. was
published, where they overexpressed a truncated HMG1 sequence
in Y. lipolytica and obtained a 134% increase in b-carotene produc-
tion in comparison to the parental strain [25]. However, a com-
parison between the performance of full and truncated HMG1
variants on enhancing isoprenoid production has not been re-
ported. In our study, the optimal combination was obtained from
co-expression of GGS1/crtE with HMG1, not truncated HMG1.
We have further investigated the potential of Y. lipolytica for
astaxanthin production. Expression of the crtS and crtR resulted in
the production of small amounts of astaxanthin intermediates, but
not astaxanthin. In S. cerevisiae expressing the same genes combi-
nation, the production of astaxanthin was very weak [8]. Expres-
sion of cytochrome P450 enzyme (crtS) and its partner in
heterologous hosts is a challenge. Improper folding or anchoring of
the proteins to the endoplasmic reticulum membrane can lead to
inactivity of the enzymes [26]. Moreover, co-localization of the two
enzymes in the same organelle is needed for proper functioning of
the pathway [8]. On the other hand, expression of bacterial cyto-
solic astaxanthin biosynthetic genes crtW and crtZ resulted in
production of astaxanthin and its intermediates in our strain.
Accumulation of intermediates rather than astaxanthin clearly
Fig. 2. Production of b-carotene in engineered Y. lipolytica strains. A. The effect of HMG-CoA reductase and GGPP synthase overexpression on b-carotene production. B. The
effect of downregulation of squalene synthase on b-carotene production. All strains were cultivated in YPþ8%glucose in 24-deep-well plates for 72 h. The error bars represent
standard deviations calculated from triplicate experiments.
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indicated that the conversion of b-carotene to astaxanthin was not
efﬁcient. Proper pathway balancing and more copies of the astax-
anthin biosynthetic enzymes were necessary to push the ﬂux to-
wards astaxanthin. We demonstrated that multiple integrations of
crtZ and crtW resulted in boosting astaxanthin production and
decreased the accumulation of intermediates. The highest astax-
anthin titer of 54.6 mg/L (3.5 mg/g DCW) was achieved in 96 deep-
well cultivation. Scaling the cultivation of this strain to controlled
bioreactors and optimizing the media and fermentation conditions
is expected to increase the titer and content much further.
Production of astaxanthin in Y. lipolyticawas previously reported in
a patent [27], but the titer or cellular content of astaxanthin were
not indicated, so it is not possible to compare the performance of
those strains to the ones generated in this study. Future efforts on
strain improvement may include overexpressing b-ketolase and
hydrolase with higher activity than bacterial crtW and crtZ e.g., bkt
and crtZ from the green algae H. pluvialis as reported in Ref. [28]. In
addition, further improvement of the mevalonate pathway ﬂux and
repressing competing pathways, such as lipid biosynthesis, are
viable strategies to address for further improving astaxanthin
Fig. 3. Astaxanthin production in Y. lipolytica. A. Astaxanthin biosynthesis pathways. The black thick arrow indicates the reactions catalyzed by the CrtW and CrtZ enzymes. The
gray dashed arrow indicates the reaction catalyzed by the CrtS enzyme. To obtain a functional expression of crtS, crtRmust be co-expressed. B. Engineered strains cultivated on YPD
agar plates for 72 h. Strain abbreviations: (A) ST3683, Wild type; (B) ST5204, b-carotene-producing non-optimized strain; (C) ST6899, b-carotene-producing optimized strain; (D)
ST6074, built by expressing crtS and crtR in ST5204; (E) ST6075, built by expressing crtW and crtZ in ST5204; (F) ST7022, built by expressing crtS and crtR in ST6899; and (G) ST7023,
built by expressing crtW and crtZ in ST6899. C. HPLC analysis of carotenoids. ST3683, wild type; b-caroop, b-carotene producer with precursor optimization [ST6899]; Astaop (crtS-
crtR), astaxanthin producer carrying crtS and crtR (precursor optimized) [ST7022]; Astaop (crtW-crtZ), astaxanthin producer carrying crtW and crtZ (precursor optimized) [ST7023]; І,
b-carotene; II, echinenone; III, canthaxanthin; IV, astaxanthin. All strains were cultivated in YPþ8%glucose in 24-deep-well plates for 72 h.
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biosynthesis in Y. lipolytica.
5. Conclusion
In this work, we engineered Y. lipolytica for the production of b-
carotene and further astaxanthin. We identiﬁed crtZ as a critical
step in conversion of b-carotene into astaxanthin and resolved this
by introducing multiple copies of the enzyme into the genome. The
astaxanthin-producing Y. lipolytica shows great promise for
employment in biological astaxanthin production.
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Fig. 4. The effect of gene copy number on astaxanthin production. A. Scheme of the strain construction process for increasing the copy number of astaxanthin biosynthetic
genes. B. HPLC analysis of carotenoids. Strain abbreviations: crtW-crtZ, astaxanthin producer carrying crtW and crtZ (precursor optimized) [ST7023]; crtW-crtZ þ crtW[[[, built by
multiple integrations of crtW in ST7023 [ST7399]; crtW-crtZ þ crtZ[[[, built by multiple integrations of crtZ in ST7023 [ST7400]; crtW-crtZ þ crtW[[[-crtZ[[[, built by multiple
integrations of crtW-crtZ in ST7023 [ST7402]. І, b-carotene; II, echinenone; III, canthaxanthin; IV, astaxanthin. C. The box plot represents the effect of gene copy number adjustment
on the production of astaxanthin and its intermediates. Different combination of additional copies of either crtW, crtZ or both genes under the control of PTEFintronwere introduced in
the astaxanthin platform strain ST7023. Strain abbreviations: Ref, reference strain ST7023; 1, ST7399; 2, ST7400; 3, ST7401; 4, ST7402; 5, ST7403; 6, ST7404; 7, ST7405; 8, ST7406. Ten
individual isolates from each construct were cultivated in YPþ8%glucose in 96 deep-well-plates for 72 h.
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Appendix A. Supplementary data
Supplementary data related to this article can be found at
https://doi.org/10.1016/j.synbio.2017.10.002.
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